Brzozowski, T. et al. 2008. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation, focus on nitric oxide and lipoxins. Journal of Physiology and Pharmacology 59, Suppl 2, 89–102.
Hucl, T. et al. 2007. High Cancer-Specific Expression of Mesothelin (MSLN) Is Attributable to an Upstream Enhancer Containing a Transcription Enhancer Factor–Dependent MCAT Motif. Cancer Res 67: 5, 9055–9065.
Hlavaty, T. et al. 2007. Predictive Model for the Outcome of Infliximab Therapy in Crohn’s Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors. Inflamm Bowel Dis. 13: 4, 372–379.
Kondrackiene, J. et al. 2007. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol. 13: 46, 6226-6230.
Vítek, L. and Schwertner, H. A. 2007. The heme catabolic pathway and its protective effects on oxidative stress–mediated diseases. Advances in Clinical Chemistry, vol. 43., 57 pp.